secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2024-02-29T23:59:59+00:00
Accession:  0001654954-24-002358
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica shareholders reject 80-for-1 reverse stock split at special meeting
----------------------------------------------------------------------------

- Share Consolidation Proposal required two-thirds approval; received only 39.44% 'for' votes.
- Final vote: 136,067,529 (39.44%) For, 206,789,223 (59.95%) Against, 2,109,080 (0.61%) Abstain.
- Proposal not approved; company retains no shareholder authorization for reverse split.
- The reverse split was likely intended to address NYSE American minimum bid price compliance.
- Failure to approve may increase risk of delisting from NYSE American.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495424002358/0001654954-24-002358-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495424002358/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-002358

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer